Analyst upgrades: UBS, PLD, AMB, NVT and PDLI
Posted Oct 2nd 2007 10:50AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Hershey Co (HSY)
MOST NOTEWORTHY: UBS AG, ProLogis, AMB Property, Navteq and PDL BioPharma were today's noteworthy upgrades:
- JP Morgan upgraded shares of UBS (NYSE: UBS) to Neutral from Underweight as they believe the company can start fresh after yesterday's pre-announcement.
- Banc of America upgraded shares of ProLogis (NYSE: PLD) and AMB Property (NYSE: AMB) to Buy from Neutral to reflect their positive outlook on global industrial REITs and believes they are positioned to benefit from global demand for industrial space.
- Navteq Corporation (NYSE: NVT) was upgraded at Deutsche Bank to Hold from Sell to reflect the acquisition by Nokia Corporation (NYSE: NOK).
- Wachovia raised shares of PDL BioPharma Inc (NASDAQ: PDLI) to Outperform from Market Perform following the CEO resignation and potential sale of the company.
OTHER UPGRADES:
Tags: amb, amb property, AmbProperty, analyst, cnxt, conexant, forest labs, ForestLabs, frx, hershey, hsy, navteq, nvt, pdl biopharma, PdlBiopharma, pdli, pld, prologis, tho, thor, ubs, upgrade
Reader Comments (Page 1 of 1)
10-02-2007 @ 11:07AM
Seth said...
UBS should be given the chance to start fresh. Although some management shakeup was necessary, the remaining board members are all quite experienced. NewsVisual created a 2-degree interactive map of the board members at UBS http://www.newsvisual.com/newsvisual/2007/10/ubs-board-ties-.html . As can be seen from the map, they are quite experienced in managing various companies and industries.